Infants : LDLo (Intramuscular ) : 10gm/kg ; Effects - Brain and coverings : meningeal changes
Infants : TDLo ( Intramuscular ) : 143 mg/kg ; Effects - Dermatits
Mouse: LD50 ( intravenous ) : 950mg/kg
Mouse : LDLo (Oral ) : 10gm/kg
Calcium gluconate is used as mineral supplement and medication when there is insufficient calcium in the diet. Supplementation may be done to treat or prevent osteoporosis or rickets, consequences of hypocalcemia. It can also be taken by mouth but is not recommended by injection into a muscle.
Calcium Gluconate Injection, USP is a sterile, nonpyrogenic supersaturated solution of calcium gluconate for intravenous use only. Each mL contains: Calcium gluconate 94 mg; calcium saccharate (tetrahydrate) 4.5 mg; water for injection q.s. Hydrochloric acid and/or sodium hydroxide may have been added for pH adjustment (6.0 to 8.2). Calcium saccharate provides 6% of the total calcium and stabilizes the supersaturated solution of calcium gluconate.
Each 10 mL of the injection provides 93 mg elemental calcium (Ca++) equivalent to 1 g of calcium gluconate.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Grepafloxacin | Calcium gluconate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enoxacin | Calcium gluconate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pefloxacin | Calcium gluconate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ciprofloxacin | Calcium gluconate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Trovafloxacin | Calcium gluconate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nalidixic acid | Calcium gluconate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rosoxacin | Calcium gluconate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cinoxacin | Calcium gluconate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lomefloxacin | Calcium gluconate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gatifloxacin | Calcium gluconate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Norfloxacin | Calcium gluconate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gemifloxacin | Calcium gluconate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ofloxacin | Calcium gluconate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sparfloxacin | Calcium gluconate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Temafloxacin | Calcium gluconate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Fleroxacin | Calcium gluconate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Technetium Tc-99m ciprofloxacin | Calcium gluconate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Garenoxacin | Calcium gluconate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nemonoxacin | Calcium gluconate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Flumequine | Calcium gluconate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enrofloxacin | Calcium gluconate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Orbifloxacin | Calcium gluconate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sarafloxacin | Calcium gluconate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Difloxacin | Calcium gluconate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pazufloxacin | Calcium gluconate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Prulifloxacin | Calcium gluconate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Delafloxacin | Calcium gluconate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sitafloxacin | Calcium gluconate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Oxolinic acid | Calcium gluconate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rufloxacin | Calcium gluconate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pipemidic acid | Calcium gluconate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ceftriaxone | The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Ceftriaxone. |
| Deferiprone | The serum concentration of Deferiprone can be decreased when it is combined with Calcium gluconate. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium gluconate. |
| Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Calcium gluconate. |
| Eltrombopag | The serum concentration of Eltrombopag can be decreased when it is combined with Calcium gluconate. |
| Estramustine | Calcium gluconate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium acetate | The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Calcium acetate. |
| Digoxin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Digoxin. |
| Acetyldigitoxin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. |
| Deslanoside | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Deslanoside. |
| Ouabain | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Ouabain. |
| Digitoxin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Digitoxin. |
| Oleandrin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Oleandrin. |
| Cymarin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Cymarin. |
| Proscillaridin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin. |
| Metildigoxin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Metildigoxin. |
| Lanatoside C | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C. |
| Gitoformate | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Gitoformate. |
| Acetyldigoxin | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigoxin. |
| Peruvoside | Calcium gluconate may increase the arrhythmogenic and cardiotoxic activities of Peruvoside. |
| Strontium ranelate | The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium gluconate. |
| Doxycycline | The serum concentration of Doxycycline can be decreased when it is combined with Calcium gluconate. |
| Lymecycline | The serum concentration of Lymecycline can be decreased when it is combined with Calcium gluconate. |
| Clomocycline | The serum concentration of Clomocycline can be decreased when it is combined with Calcium gluconate. |
| Oxytetracycline | The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium gluconate. |
| Demeclocycline | The serum concentration of Demeclocycline can be decreased when it is combined with Calcium gluconate. |
| Tetracycline | The serum concentration of Tetracycline can be decreased when it is combined with Calcium gluconate. |
| Metacycline | The serum concentration of Metacycline can be decreased when it is combined with Calcium gluconate. |
| Minocycline | The serum concentration of Minocycline can be decreased when it is combined with Calcium gluconate. |
| Sarecycline | The serum concentration of Sarecycline can be decreased when it is combined with Calcium gluconate. |
| Omadacycline | The serum concentration of Omadacycline can be decreased when it is combined with Calcium gluconate. |
| Penimepicycline | The serum concentration of Penimepicycline can be decreased when it is combined with Calcium gluconate. |
| Methyclothiazide | Methyclothiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Chlorthalidone | Chlorthalidone may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Bendroflumethiazide | Bendroflumethiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Metolazone | Metolazone may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Benzthiazide | Benzthiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Hydroflumethiazide | Hydroflumethiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Indapamide | Indapamide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Chlorothiazide | Chlorothiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Hydrochlorothiazide | Hydrochlorothiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Trichlormethiazide | Trichlormethiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Polythiazide | Polythiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Quinethazone | Quinethazone may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Cyclopenthiazide | Cyclopenthiazide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Epitizide | Epitizide may decrease the excretion rate of Calcium gluconate which could result in a higher serum level. |
| Triethylenetetramine | Calcium gluconate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcitriol | The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcium gluconate. |
| Calcifediol | The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium gluconate. |
| Paricalcitol | The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium gluconate. |
| Dihydrotachysterol | The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium gluconate. |
| Alfacalcidol | The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium gluconate. |
| Calcipotriol | The risk or severity of adverse effects can be increased when Calcipotriol is combined with Calcium gluconate. |
| Seocalcitol | The risk or severity of adverse effects can be increased when Seocalcitol is combined with Calcium gluconate. |
| Inecalcitol | The risk or severity of adverse effects can be increased when Inecalcitol is combined with Calcium gluconate. |
| Becocalcidiol | The risk or severity of adverse effects can be increased when Becocalcidiol is combined with Calcium gluconate. |
| Eldecalcitol | The risk or severity of adverse effects can be increased when Eldecalcitol is combined with Calcium gluconate. |
| 1alpha,24S-Dihydroxyvitamin D2 | The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Calcium gluconate. |
| Elocalcitol | The risk or severity of adverse effects can be increased when Elocalcitol is combined with Calcium gluconate. |
| Maxacalcitol | The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Calcium gluconate. |
| Doxercalciferol | The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Calcium gluconate. |
| 1alpha-Hydroxyvitamin D5 | The risk or severity of adverse effects can be increased when 1alpha-Hydroxyvitamin D5 is combined with Calcium gluconate. |
| Tacalcitol | The risk or severity of adverse effects can be increased when Tacalcitol is combined with Calcium gluconate. |
| Previtamin D(3) | The risk or severity of adverse effects can be increased when Previtamin D(3) is combined with Calcium gluconate. |
| Isradipine | The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium gluconate. |
| Diltiazem | The therapeutic efficacy of Diltiazem can be decreased when used in combination with Calcium gluconate. |
| Trimethadione | The therapeutic efficacy of Trimethadione can be decreased when used in combination with Calcium gluconate. |
| Amlodipine | The therapeutic efficacy of Amlodipine can be decreased when used in combination with Calcium gluconate. |
| Nimodipine | The therapeutic efficacy of Nimodipine can be decreased when used in combination with Calcium gluconate. |